| Literature DB >> 26827951 |
Vaishali Veldurthy1, Ran Wei1, Megan Campbell1, Kamil Lupicki1, Puneet Dhawan1, Sylvia Christakos2.
Abstract
One of the most pronounced effects of the hormonally active form of vitamin D, 1,25-dihydroxyvitamin D3 (1,25(OH)2D3), is increased synthesis of 25-hydroxyvitamin D3 24-hydroxylase (CYP24A1), the enzyme responsible for the catabolism of 1,25(OH)2D3. Thus, 1,25(OH)2D3 regulates its own metabolism, protecting against hypercalcemia and limiting the levels of 1,25(OH)2D3 in cells. This chapter summarizes the catalytic properties of CYP24A1, the recent data related to the crystal structure of CYP24A1, the findings obtained from the generation of mice deficient for the Cyp24a1 gene as well as recent data identifying a causal role of a genetic defect in CYP24A1 in certain patients with idiopathic infantile hypercalcemia. This chapter also reviews the regulation of renal and placental CYP24A1 as well as the genomic mechanisms, including coactivators, repressors, and epigenetic modification, involved in modulating 1,25(OH)2D3 regulation of CYP24A1. We conclude with future research directions related to this key regulator of 1,25(OH)2D3 catabolism and calcium homeostasis.Entities:
Keywords: 25-Hydroxyvitamin D(3) 24-hydroxylase; Fibroblast growth factor 23; Parathyroid hormone; Transcription; Vitamin D receptor
Mesh:
Substances:
Year: 2016 PMID: 26827951 DOI: 10.1016/bs.vh.2015.10.005
Source DB: PubMed Journal: Vitam Horm ISSN: 0083-6729 Impact factor: 3.421